29 June: G20 places dementia prominently on its agenda

On 28-29 June 2019, the leaders of the G20 met in Osaka, Japan, to address major global economic challenges. For the first time, dementia was specifically recognised as a global health priority in the declaration of the summit.

Read more »
Rate: 12345 (0) | Facebook Twitter
1 July: Brain health should be a priority for Horizon Europe

The draft strategic plan for Horizon Europe has shown brain research is being hugely undervalued. Together with 17 other organisations, we are calling for this to be rectified. Please support this campaign.

Read more »
Rate: 12345 (0) | Facebook Twitter
11 July: Novartis and Amgen stop Phase II/III clinical studies

On 11 July, the pharmaceutical companies Novartis and Amgen announced the decision to discontinue two Phase II/III clinical trials in the Alzheimer's Prevention Initiative (API) Generation programme based on a planned analysis

Read more »
Rate: 12345 (0) | Facebook Twitter
16 July: First ever female Commission President confirmed

The newly-elected European Parliament has voted to confirm the first female President of the European Commission, Ursula von der Leyen. Ms von der Leyen is the first ever female Commission President.

Read more »
Rate: 12345 (0) | Facebook Twitter
31 July: New trials added to the Clinical Trials Watch

Alzheimer Europe continues to develop and improve its Clinical Trials Watch (CTW), an innovative online resource providing up-to-date accessible information on clinical trials currently recruiting participants in a least one European country.

Read more »
Rate: 12345 (0) | Facebook Twitter